Home The Word Brain My Amedeo FAQ Privacy About   


Explore this week’s CC Journal Club

90‑sec video • 4‑min audio • paper abstracts

This week, 27 April 2025:

  1. Treatment-resistant hypertension
  2. Influenza transmission
  3. Nanoplastics in human brains
  4. Malaria elimination
  5. Chikungunya vaccine

  Gastric Cancer

  Free Subscription


Articles published in Oncology

Retrieve available abstracts of 21 articles:
HTML format



Single Articles


    February 2025
  1. SHANG H, Fang Y, Zhao Y, Mi N, et al
    Deep learning and radiomics for gastric cancer lymph node metastasis: Automated segmentation and multi-machine learning study from two centers.
    Oncology. 2025 Feb 13:1-20. doi: 10.1159/000544179.
    PubMed     Abstract available


    December 2024
  2. ZHAO T, Wu Q, Zhu C, Da M, et al
    Diagnostic value of artificial intelligence-based pathology diagnosis system in lymphatic metastasis of gastric cancer.
    Oncology. 2024 Dec 2:1-13. doi: 10.1159/000542852.
    PubMed     Abstract available


    November 2024
  3. JI Z, Zhu L, Wang X, Li H, et al
    Clinicopathological Characteristics and Perioperative Treatment of Epstein-Barr Virus-Associated Gastric Cancer: A Retrospective Study.
    Oncology. 2024 Nov 1. doi: 10.1159/000542369.
    PubMed     Abstract available


    October 2024
  4. NAKAZAWA N, Sano A, Kumakura Y, Yamashita T, et al
    Prognostic Nutrition Index as a Biomarker for Treatment Sensitivity to Chemotherapy and Nivolumab as the First-Line Treatment in Patients with Unresectable Advanced or Recurrent Gastric Cancer: A Multicenter Study.
    Oncology. 2024 Oct 24:1-17. doi: 10.1159/000541544.
    PubMed     Abstract available


    September 2024
  5. HU Q, Kudo K, Yukaya T, Hasuda H, et al
    Clinical impact of skeletal muscle mass and nutritional status in patients with recurrent or advanced gastric cancer treated with nivolumab.
    Oncology. 2024 Sep 12:1-17. doi: 10.1159/000540840.
    PubMed     Abstract available


  6. NAKAZAWA N, Sohda M, Hosoi N, Watanabe T, et al
    Identification of biomarkers for assessing treatment efficacy of chemotherapy plus nivolumab as the first line in patients with unresectable advanced or recurrent gastric cancer: a multicenter study.
    Oncology. 2024 Sep 12:1-17. doi: 10.1159/000540841.
    PubMed     Abstract available


  7. NAKAMURA K, Suehiro Y, Hamabe K, Goto A, et al
    A Novel Index Including Age, Sex, hTERT, and Methylated RUNX3 Is Useful for Diagnosing Early Gastric Cancer.
    Oncology. 2024 Sep 5:1-14. doi: 10.1159/000541173.
    PubMed     Abstract available


    July 2024
  8. UCAR G, Sekmek S, Karahan I, Ergun Y, et al
    The Comparison of FLOT and DCF Regimens as Perioperative Treatment for Gastric Cancer.
    Oncology. 2024 Jul 30. doi: 10.1159/000540517.
    PubMed     Abstract available


    February 2024
  9. NEDOVIC VUKOVIC M, Jaksic M, Smolovic B, Lukic M, et al
    Trends in gastric cancer mortality in Montenegro, 1990 - 2018: joinpoint regression.
    Oncology. 2024 Feb 19. doi: 10.1159/000537739.
    PubMed     Abstract available


  10. UNAL OU, Akay S, Gul G, Keser M, et al
    Impact of HER2-Low status in metastatic gastric cancer:A real-world retrospective cohort study.
    Oncology. 2024 Feb 14. doi: 10.1159/000537839.
    PubMed     Abstract available


    January 2024
  11. JEON C, Kang SH, Kim SB, Paik NS, et al
    Safety and Effectiveness of Trastuzumab Biosimilar SB3 in Korean Patients, a Post-Marketing Surveillance Study.
    Oncology. 2024;102:465-475.
    PubMed     Abstract available


    December 2023
  12. YAMAMOTO M, Omori T, Shinno N, Hara H, et al
    Prognostic value of a novel index combining the prognostic nutritional index and D-dimer levels for gastric cancer after gastrectomy.
    Oncology. 2023 Dec 30. doi: 10.1159/000533150.
    PubMed     Abstract available


    October 2023
  13. ISHIKAWA A, Yasumatsu R, Fukui T, Kido A, et al
    Kinesin family member B18 is related to gastric mucin phenotype and contributes to gastric cancer progression by regulating epithelial-mesenchymal transition.
    Oncology. 2023 Oct 9. doi: 10.1159/000533791.
    PubMed     Abstract available


    September 2023
  14. CORSO G, Trovato CM, Petitto S, Girardi A, et al
    Clinical implication of CDH1 mutations in genetic testing for diffuse gastric cancer patients.
    Oncology. 2023 Sep 19. doi: 10.1159/000533774.
    PubMed     Abstract available


  15. MA J, Da M
    High-mobility group box 1 overexpression predicts a poor prognosis and promotes EMT in gastric cancer by activating TLR4/NF-kappaB signaling.
    Oncology. 2023 Sep 4. doi: 10.1159/000533927.
    PubMed     Abstract available


    July 2023
  16. FUJIMOTO D, Taniguchi K, Takashima J, Kobayashi H, et al
    Postoperative early body weight loss is a risk factor for recurrence in patients with pStage III gastric cancer.
    Oncology. 2023 Jul 26. doi: 10.1159/000532089.
    PubMed     Abstract available


    June 2023
  17. NAKAZAWA N, Sohda M, Katayama A, Ide M, et al
    Infiltration of Gastric Cancer Stroma by Tumor-Infiltrating Lymphocytes Correlates with mTOR Signaling.
    Oncology. 2023 Jun 14. doi: 10.1159/000531475.
    PubMed     Abstract available


  18. PECORA I, Ugolini C, Giannini R, Giordano M, et al
    Dynamic profiling of the immune tumor microenvironment in locally advanced gastric cancer treated with perioperative chemotherapy.
    Oncology. 2023 Jun 12. doi: 10.1159/000530853.
    PubMed     Abstract available


  19. CHENG R, Peng Y, Sun X, Zhang S, et al
    Circulating tumor cells as diagnostic markers of early gastric cancer and gastric precancerous lesions.
    Oncology. 2023 Jun 1. doi: 10.1159/000531323.
    PubMed     Abstract available


    May 2023
  20. ABEDINI F, Amjadi O, Hedayatizadeh-Omran A, Lira S, et al
    Serotonin Receptors and Acetylcholinesterase Gene Expression Alternations: The Potential Value on Tumor Microenvironment of Gastric Cancer.
    Oncology. 2023 May 3:1. doi: 10.1159/000530878.
    PubMed     Abstract available


    January 2023
  21. HINGORANI M, Goody R, Bozas G, Zahid K, et al
    Neoadjuvant Management of Adenocarcinoma of the Esophagus and Esophagogastric Junction: Review of Randomized Evidence and Definition of Optimum Treatment Algorithm.
    Oncology. 2023;101:553-564.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Gastric Cancer is free of charge.